2025 RNDS | New and Emerging Therapeutics @wearesrna
2025 RNDS | New and Emerging Therapeutics  @wearesrna
Uploaded December 2025 | Updated November 2026, 2 hours ago
In this presentation at the 2025 Virtual RNDS, Dr. Stacey Clardy discussed how drugs are created and implemented. Steps include finding a target or a biomarker, finding optimal drugs to create biomarker impact, and then proceeding to clinical trials. She covered treatments for NMOSD, like B-depleters, complement inhibitors, and IL-6 inhibitors. She then discussed the ongoing MOG trials and the PLEX trial. She highlighted the importance of checking clinicaltrials.gov and asking your neurologist what all is in the pipeline for the future.
2025 RNDS | New and Emerging Therapeutics2023 RNDS en Español | ¿Qué es MOGAD y EMAD?1115. A Conversation about Grief and Loss with Chris Lopardi201. Dr. Cristina Sadowsky1303. Parenting is Hard | Part 12025 RNDS | Tips and tricks to obtain access to care; Transition from pediatric to adult care1213. Operant Conditioning Rehabilitation Studies1305. FES 101SRNA | The Power of Community2026 RNDS | Research Updates on Muscle Evoked Potential Operant Conditioning (EPOC) Studies102. Meteoroid and cosMOG Clinical Trials for MOGAD Treatments1216. Transcutaneous Spinal Stimulation
SRNA |

2025 RNDS | New and Emerging Therapeutics

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER